You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 8 No. 3, March 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chlorpromazine-Induced Weakness in Myasthenia Gravis

MICHAEL P. McQUILLEN, M.D.; MARTIN GROSS, M.D.; SYKESVILLE, MD; RICHARD J. JOHNS, M.D.

Arch Neurol. 1963;8(3):286-290.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the management of myasthenia gravis, it is important to avoid the use of medications such as curare and quinine which make the neuromuscular block worse. Shortly after the discovery of chlorpromazine, animal studies suggested some actions which might be deleterious to myasthenic patients.1,2,7,9-11 However, no clinical report confirming such adverse effects in myasthenia has appeared.

When a psychotic myasthenic patient became weaker after oral chlorpromazine, study was made of the nature of this worsening. The results of that investigation form the basis of this report.

Report of a Case

This patient was the subject of an extensive report 21 years ago.5 Thus, only findings pertinent to the present study are detailed here.

The patient was born in 1902. He was struck on the head with a baseball bat in 1918 and was unconscious for 5 to 6 hr.; a left peripheral facial paresis was the only sequela. . . . [Full Text PDF of this Article]


Author Affiliations

BALTIMORE; BALTIMORE

From the Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore (Dr. McQuillen and Dr. Johns), and the Springfield State Hospital, Sykesville, Md. (Dr. Gross).

Fellow in Medicine, The Johns Hopkins University (Dr. McQuillen); Research Director, Springfield State Hospital (Dr. Gross); Associate Professor of Medicine, The Johns Hopkins University (Dr. Johns).


Footnotes

Submitted for publication July 12, 1962.

Aided by Grants B-894 and MY-3672 from the National Institute of Neurological Diseases and Blindness, National Institutes of Health, U.S. Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.